Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harrow Inc (NQ: HROW ) 24.59 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 24.59 Bid (Size) 23.83 (5) Ask (Size) 28.10 (6) Prev. Close 24.59 Today's Range 24.59 - 24.59 52wk Range 7.600 - 25.58 Shares Outstanding 35,382 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Harrow to Attend 2024 ASRS Annual Meeting July 12, 2024 From Harrow, Inc. Via Business Wire Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products July 09, 2024 From Harrow, Inc. Via Business Wire Performance YTD +105.77% +105.77% 1 Month +39.32% +39.32% 3 Month +126.64% +126.64% 6 Month +150.15% +150.15% 1 Year +14.21% +14.21% More News Read More Top 3 Health Care Stocks That May Crash This Quarter July 03, 2024 Via Benzinga HROW Stock Earnings: Harrow Beats EPS, Beats Revenue for Q2 2023 July 02, 2024 Via InvestorPlace Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday June 20, 2024 Via Benzinga Harrow Provides TRIESENCE® Relaunch Update June 20, 2024 From Harrow, Inc. Via Business Wire The Top 7 Growth Stocks to Buy and Hold Until 2030 June 07, 2024 Via InvestorPlace Melt Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 Program of Its Lead Product Candidate, MELT-300, for Needle- and Opioid-Free Sedation in Patients Undergoing Cataract Surgery June 06, 2024 From Melt Pharmaceuticals, Inc. Via Business Wire Harrow Announces 52-Week Data from VEVYE® ESSENCE-2 Open-Label Extension Study June 05, 2024 From Harrow, Inc. Via Business Wire 3 Stocks Insiders are Buying That Should be on Your Radar May 28, 2024 Via MarketBeat Harrow to Present at Two Investor Conferences in May May 15, 2024 From Harrow, Inc. Via Business Wire Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 14, 2024 Via Benzinga Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday May 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 14, 2024 Via Benzinga HROW Stock Earnings: Harrow Health Misses EPS, Misses Revenue for Q1 2024 May 13, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session May 13, 2024 Via Benzinga Harrow Announces First Quarter 2024 Financial Results May 13, 2024 From Harrow, Inc. Via Business Wire Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial May 13, 2024 From Harrow, Inc. Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session May 03, 2024 Via Benzinga Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024 April 25, 2024 From Harrow, Inc. Via Business Wire Around $2M Bet On This Industrial Stock? Check Out These 3 Stocks Insiders Are Buying April 25, 2024 Via Benzinga Over $24M Bet On RXO? Check Out These 3 Stocks Insiders Are Buying April 22, 2024 Via Benzinga Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing April 02, 2024 From Melt Pharmaceuticals, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
